Tech Company Financing Transactions
Principia Biopharma Funding Round
Principia Biopharma, based in South San Francisco, secured $3 million from Morgenthaler Ventures.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Morgenthaler Ventures (Nassim Usman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
400 East Jamie Ct. 302
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Principia is committed to changing the drug development paradigm. The company's reversible covalent technology platform rapidly and reliably produces compounds with superior selectivity, enabling development of multiple product candidates with substantial commercial potential.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Babler
Chief Financial Officer
Christopher Chai
Chief Medical Officer
Steve Gourlay
Chief Scientific Officer
Jens Funk
Vice President
Ken Brameld
VP - Bus. Development
Roy Hardiman
VP - Human Resources
Betsy Santos
VP - Operations
Ann Neale
VP - Operations
Stefani Wolff
Browse more venture capital transactions:
Prev: 9/30/2013: Twist Bioscience venture capital transaction
Next: 9/30/2013: Bag Borrow or Steal venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs